Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin antiproliferative effects in endometrial cancer
jRCTs031180339Active, not recruiting
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin in endometrial cancer (EC). Primary endpoint: Change in H19 expression in endometrial cancer tissue. Started May 2016; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on jRCTs031180339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180339.